stella
beta
An Open-label Single Center, Proof of Concept Study Evaluating the Efficacy of Roflumilast Foam 0.3% in Pediatric Patients With Non-Segmental Vitiligo (NSV) — Stella
Recruiting
Back to Non-segmental Vitiligo trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(1 site)
United States
Derm Texas, Dallas, Texas
View full record on ClinicalTrials.gov